HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population

BMC Dermatology

Volumn 14, Issue , 2014, Pages

  Gao, Xiang ^a,b   Han, Lei ^b   Yuan, Lan ^c,d   Yang, Yongchen ^e   Gou, Guimei ^e   Sun, Hengjuan ^e   Lu, Ling ^b   Bao, Liming ^c,d,f  

^a WEIFANG PEOPLE'S HOSPITAL   (China)

^b FUDAN UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^e SHANGHAI CHILDREN S HOSPITAL   (China)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Chinese; Dermatomyositis; HLA; Polymyositis; Susceptibility

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HLA DQ ANTIGEN; HLA-DQA1 ANTIGEN; HLA-DQB1 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAN CHINESE; HAPLOTYPE; HLA ANTIGEN CLASS 2 ALLELE; HLA DQA1 ALLELE; HLA DQB1 ALLELE; HLA DRB1 ALLELE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATHOGENESIS; PNEUMONIA; POLYMYOSITIS; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DERMATOMYOSITIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ALPHA-CHAINS; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMYOSITIS; RISK FACTORS;

EID: 84902658143     PISSN: None     EISSN: 14715945     Source Type: Journal    
DOI: 10.1186/1471-5945-14-9     Document Type: Article

References (31)

1. Mammen AL. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 2010, 1184:134-153. 10.1111/j.1749-6632.2009.05119.x, 20146695.
2. Luppi P, Rossiello MR, Faas S, Trucco M. Genetic background and environment contribute synergistically to the onset of autoimmune diseases. J Mol Med (Berl) 1995, 73(8):381-393.
3. Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. Transpl Immunol 2005, 14(3-4):175-182.
4. O'Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Rider LG, Chanock SJ, Foster CB, Bunch T, Blackshear PJ, Plotz PH, Love LA, Miller FW. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 2006, 85(2):111-127. 10.1097/01.md.0000217525.82287.eb, 16609350.
5. Seldin MF, Amos CI, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999, 42(6):1071-1079. 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8, 10366098.
6. McLeod R, Buschman E, Arbuckle LD, Skamene E. Immunogenetics in the analysis of resistance to intracellular pathogens. Curr Opin Immunol 1995, 7(4):539-552. 10.1016/0952-7915(95)80100-6, 7495519.
7. Arnett FC, Targoff IN, Mimori T, Goldstein R, Warner NB, Reveille JD. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996, 39(9):1507-1518. 10.1002/art.1780390910, 8814062.
8. Reed AM, Pachman LM, Hayford J, Ober C. Immunogenetic studies in families of children with juvenile dermatomyositis. J Rheumatol 1998, 25(5):1000-1002.
9. Furuya T, Hakoda M, Higami K, Ueda H, Tsuchiya N, Tokunaga K, Kamatani N, Kashiwazaki S. Association of HLA class I and class II alleles with myositis in Japanese patients. J Rheumatol 1998, 25(6):1109-1114.
10. Han X, Zhai N, Zhang Y, LI J, Liu J, Song F, Cehn H. Association of HLA-DRB1 alleles and polymyositis/dermatomyositis in northen Chinese. Chin J Microbiol Immunol 2003, 23(3):225-227.
11. Han X, Zhai N, Zhang Q, Li J, Liu J, Du J, Song F. Association of HLA-DQB1 alleles and dermatomyositis/ polymyositis. Chin J Med Genet 2002, 19(4):322-323.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975, 292(8):403-407. 10.1056/NEJM197502202920807, 1089199.
13. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292(7):344-347. 10.1056/NEJM197502132920706, 1090839.
14. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993, 41(3):119-134. 10.1111/j.1399-0039.1993.tb01991.x, 8316943.
15. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992, 39(5):225-235. 10.1111/j.1399-0039.1992.tb01940.x, 1357775.
16. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68(4):978-989. 10.1086/319501, 1275651, 11254454.
17. Engel AG, Arahata K, Emslie-Smith A. Immune effector mechanisms in inflammatory myopathies. Res Publ Assoc Res Nerv Ment Dis 1990, 68:141-157.
18. Robinson AB, Reed AM. Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol 2011, 7(11):664-675. 10.1038/nrrheum.2011.139, 21947177.
19. Shamim EA, Rider LG, Pandey JP, O'Hanlon TP, Jara LJ, Samayoa EA, Burgos-Vargas R, Vazquez-Mellado J, Alcocer-Varela J, Salazar-Paramo M, Kutzbach AG, Malley JD, Targoff IN, Garcia-De la Torre I, Miller FW. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis. Arthritis Rheum 2002, 46(7):1885-1893. 10.1002/art.10358, 12124873.
20. Chinoy H, Salway F, Fertig N, Oddis CV, Ollier WE, Cooper RG. Clinical, serological and HLA profiles in non-Caucasian UK idiopathic inflammatory myopathy. Rheumatology (Oxford) 2009, 48(5):591-592.
21. Marie I, Hachulla E, Levesque H, Reumont G, Ducrotte P, Cailleux N, Hatron PY, Devulder B, Courtois H. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol 1999, 26(12):2706-2709.
22. O'Hanlon TP, Rider LG, Mamyrova G, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Chanock SJ, Foster CB, Bunch T, Reed AM, Love LA, Miller FW. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum 2006, 54(11):3670-3681. 10.1002/art.22205, 17075818.
23. Yu KH, Wu YJ, Kuo CF, See LC, Shen YM, Chang HC, Luo SF, Ho HH, Chen IJ. Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. Clin Rheumatol 2011, 30(12):1595-1601. 10.1007/s10067-011-1840-0, 21915609.
24. Kuo CF, See LC, Yu KH, Chou IJ, Chang HC, Chiou MJ, Luo SF. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol 2011, 165(6):1273-1279. 10.1111/j.1365-2133.2011.10595.x, 21895620.
25. Chinoy H, Lamb JA, Ollier WE, Cooper RG. Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther 2011, 13(3):216. 10.1186/ar3327, 3218878, 21658295.
26. Furuya T, Hakoda M, Tsuchiya N, Kotake S, Ichikawa N, Nanke Y, Nakajima A, Takeuchi M, Nishinarita M, Kondo H, Kawasaki A, Kobayashi S, Mimori T, Tokunaga K, Kamatani N. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. J Rheumatol 2004, 31(9):1768-1774.
27. Rider LG, Shamim E, Okada S, Pandey JP, Targoff IN, O'Hanlon TP, Kim HA, Lim YS, Han H, Song YW, Miller FW. Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis Rheum 1999, 42(6):1285-1290. 10.1002/1529-0131(199906)42:6<1285::AID-ANR28>3.0.CO;2-1, 10366124.
28. Chinoy H, Salway F, Fertig N, Shephard N, Tait BD, Thomson W, Isenberg DA, Oddis CV, Silman AJ, Ollier WE, Cooper RG. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res Ther 2006, 8(1):R13. 10.1186/ar1862, 1526560, 16507114.
29. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991, 70(6):360-374.
30. Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, Jarzabek-Chorzelska M, Targoff IN, Blaszczyk-Kostanecka M, Jablonska S. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997, 40(7):1257-1266. 10.1002/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R, 9214426.
31. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008, 371(9631):2201-2212. 10.1016/S0140-6736(08)60955-1, 18586175.